Comparative study of deoxynivalenol, 3-acetyldeoxynivalenol, and 15-acetyldeoxynivalenol on intestinal transport and IL-8 secretion in the human cell line Caco-2

Toxicology in Vitro

Volumn 27, Issue 6, 2013, Pages 1888-1895

  Kadota, Tomoyuki ^a,b   Furusawa, Hiroko ^c   Hirano, Satoshi ^a   Tajima, Osamu ^a   Kamata, Yoichi ^d   Sugita Konishi, Yoshiko ^e  

^a KIRIN HOLDINGS CO LTD   (Japan)

^b GIFU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d IWATE UNIVERSITY   (Japan)

^e AZABU UNIVERSITY   (Japan)

Author keywords

Acetyldeoxynivalenol; Caco 2 cells; IL 8; Transepithelial transport; Trichothecene

Indexed keywords

15 ACETYLVOMITOXIN; 3 ACETYLDEOXYNIVALENOL; INTERLEUKIN 8; LUCIFER YELLOW; MESSENGER RNA; MYCOTOXIN; UNCLASSIFIED DRUG; VOMITOXIN;

ACETYLATION; ARTICLE; CELL FUNCTION; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CELL TRANSPORT; CELLULAR PARAMETERS; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DNA MICROARRAY; GENE EXPRESSION; GENE INDUCTION; HEALTH HAZARD; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; INTESTINE EPITHELIUM; PERMEABILITY BARRIER; RISK ASSESSMENT; TRANSEPITHELIAL ELECTRICAL RESISTANCE;

ACETYLDEOXYNIVALENOL; CACO-2 CELLS; IL-8; TRANSEPITHELIAL TRANSPORT; TRICHOTHECENE;

BIOLOGICAL TRANSPORT; CACO-2 CELLS; CELL SURVIVAL; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-8; INTESTINAL ABSORPTION; INTESTINES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRICHOTHECENES;

EID: 84880370960     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2013.06.003     Document Type: Article

References (46)

1. Al-Sadi R., Ye D., Dokladny K., Ma T.Y. Mechanism of IL-1β-induced increase in intestinal epithelial tight junction permeability. J. Immunol. 2008, 180:5653-5661.
2. Artursson P., Palm K., Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug. Deliv. Rev. 2001, 46:27-43.
3. Berger V., Gabriel A.F., Sergent T., Trouet A., Larondelle Y., Schneider Y.J. Interaction of ochratoxin A with human intestinal Caco-2 cells: possible implication of a multidrug resistance-associated protein (MRP2). Toxicol. Lett. 2003, 140:465-476.
4. Bracarense A.-P.F.L., Lucioli J., Grenier B., Pacheco G.D., Moll W.-D., Schatzmayr G., Oswald I.P. Chronic ingestion of deoxynivalenol and fumonisin, alone or in interaction, induces morphological and immunological changes in the intestine of piglets. Br. J. Nutr. 2012, 107:1776-1786.
5. Cano P.M., Seeboth J., Meurens F., Cognie J., Abrami R., Oswald I.P., Guzylack-Piriou L. Deoxynivalenol as a new factor in the persistence of intestinal inflammatory diseases: An emerging hypothesis through possible modulation of Th17-mediated response. PLOS ONE 2013, 8:e53647.
6. Casteel M., Nielsen C., Didlier A., Dietrich R., Martlbauer E. Induction of MAPK-dependent transcription factors by deoxynivalenol in human cell lines. Mycotox. Res. 2010, 26:9-14.
7. Chanput W., Mes J., Vreeburg R.A.M., Savelkoul H.F.J., Wichers H.J. Transcription profiles of LPS-stimulated THP-1 monocytes and macrophages: a tool to study inflammation modulating effects of food-derived compounds. Food Funct. 2010, 1:254-261.
8. Choi H.J., Yang H., Park S.H., Moon Y. HuR/ELAVL1 RNA binding protein modulates interleukin-8 induction by muco-active ribotoxin deoxynivalenol. Toxicol. Appl. Pharmacol. 2009, 240:46-54.
9. De Walle J.V., Sergent T., Piront N., Toussaint O., Schneider Y.J., Larondelle Y. Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis. Toxicol. Appl. Pharmacol. 2010, 245:291-298.
10. Diesing A.-K., Nossol C., Panther P., Walk N., Post A., Kluess J., Kreutzmann P., Dänicke S., Rothkötter H.-J., Kahlert S. Mycotoxin deoxynivalenol (DON) mediates biphasic cellular response in intestinal porcine epithelial cell lines IPEC-1 and IPEC-J2. Toxicol. Lett. 2011, 200:8-18.
11. Eriksen G.S., Pettersson H., Lindberg J.E. Absorption, metabolism and excretion of 3-acetyl don in pigs. Arch. Anim. Nutr. 2001, 57:335-345.
12. Eriksen G.S., Pettersson H., Johnsen K., Lindberg J.E. Transformation of trichothecenes in ileal digesta and faeces from pigs. Arch. Tierernahr. 2002, 56:263-274.
13. Eriksen G.S., Pettersson H., Lindberg J.E. Absorption, metabolism and excretion of 3-acetyl DON in pigs. Arch. Tierernahr. 2003, 57:335-345.
14. Etienne W., Meyer M.H., Peppers J., Meyer R.A. Comparison of mRNA gene expression by RT-PCR and DNA microarray. BioTechniques 2004, 36:618-621.
15. FDA, 2006. Drug Interaction Studies - Study Design, Data Analysis, and Implications for Dosing and Labeling. .
16. Forcell J.H., Jensen R., Tai J.H., Witt M., Lin W.S., Pestka J.J. Comparison of acute toxicities of deoxynivalenol (vomitoxin) and 15-acetyldeoxynivalenol in the B6C3F1 mouse. Food Chem. Toxicol. 1987, 25:155-162.
17. Hurni M.A., Noach A.B., Blom-Roosemalen M.C., De-Boer A.G., Nagelkerke J.F., Breimer D.D. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy. J. Pharmacol. Exp. Ther. 1993, 267:942-950.
18. Iverson F., Armstrong C., Nera E., Truelove J., Fernie S., Scott P., Stapley R., Hayward S., Gunner S. Chronic feeding study of deoxynivalenol in B6C3F1 male and female mice. Terat. Carcinog. Mutagen. 1995, 15:283-306.
19. JECFA Safety evaluation of certain mycotoxins in food. WHO Food Additives Series 47 2001, World Health Organization, Geneva.
20. JECFA, 2010. JOINT FAO/WHO EXPERT COMMITTEE ON FOOD ADDITIVES Seventy-second meeting Rome, 16-25 February 2010.
21. JECFA Evaluation of certain contaminations in food. WHO Technical Report Series 959 2011, World Health Organization, Geneva.
22. Kasuga F., Hara-Kudo Y., Saito N., Kumagai S., Sugita-Konishi Y. In vitro effect of deoxynivalenol on the differentiation of human colonic cell lines Caco-2 and T84. Mycopathologia 1998, 142:161-167.
23. Kinser S., Li M., Jia Q., Pestka J.J. Truncated deoxynivalenol-induced splenic immediate early gene response in mice consuming (n-3) polyunsaturated fatty acids. J. Nutr. Biochem. 2005, 16:88-95.
24. Maresca M., Yahi N., Younès-Sakr L., Boyron M., Caporiccio B., Fantini J. Both direct and indirect effects account for the pro-inflammatory activity of enteropathogenic mycotoxins on the human intestinal epithelium: stimulation of interleukin-8 secretion, potentiation of interleukin-1beta effect and increase in the transepithelial passage of commensal bacteria. Toxicol. Appl. Pharmacol. 2008, 228:84-92.
25. Mikami O., Kubo M., Murata H., Muneta Y., Nakajima Y., Miyazaki S., Tanimura N., Katsuda K. The effects of acute exposure to deoxynivalenol on some inflammatory parameters in miniature pigs. J. Vet. Med. Sci. 2011, 73:665-671.
26. Moon Y., Uzarski R., Pestka J.J. Relationship of trichothecene structure to COX-2 induction in the macrophage: selective action of type B (keto-8) trichothecenes. J. Toxicol. Environ. Health A. 2003, 66:1967-1983.
27. Nielsen C., Lippke H., Didier A., Dietrich R., Märtlbauer E. Potential of deoxynivalenol to induce transcription factors in human hepatoma cells. Mol. Nutr. Food Res. 2009, 53:479-491.
28. Pellegrina C.D., Perbellini O., Scupoli M.T., Tomelleri C., Zanetti C., Zoccatelli G., Fusi M., Peruffo A., Rizzi C., Chignola R. Effect of wheat germ agglutinin on human gastrointestinal epithelium: insight from an experimental model of immune/epithelial cell interaction. Toxicol. Appl. Pharmacol. 2009, 237:146-153.
29. Pestka J.J. Deoxynivalenol: mechanisms of action, human exposure, and toxicological relevance. Arch. Toxicol. 2010, 84:663-679.
30. Pestka J.J., Smolinski A.T. Deoxynivalenol: toxicology and potential effects on humans. J. Toxicol. Environ. Health B Crit. Rev. 2005, 8(39):69.
31. Pestka J.J., Uzarski R.L., Islam Z. Induction of apoptosis and cytokine production in the Jurkat human T cell by deoxynivalenol: role of mitogen-activated protein kinases and comparison to other 8-ketotrichothecenes. Toxicology 2005, 206:207-219.
32. Pfeiffer E., Kommer A., Dempe J.S., Hildebrand A.A., Metzler M. Absorption and metabolism of the mycotoxin zearalenone and the growth promotor zeranol in Caco-2 cells in vitro. Mol. Nutr. Food Res. 2010, 55:560-567.
33. Pinton P., Nougayrède J.P., Del Rio J.C., Moreno C., Marin D.E., Ferrier L., Bracarense A.P., Kolf-Clauw M., Oswald I.P. The food contaminant deoxynivalenol, decreases intestinal barrier permeability and reduces claudin expression. Toxicol. Appl. Pharmacol. 2009, 237:41-48.
34. Pinton P., Tsybulskyy D., Lucioli J., Laffitte J., Callu P., Lyazhri F., Grosjean F., Bracarense A.P., Kolf-Clauw M., Oswald I.P. Toxicity of deoxynivalenol and its acetylated derivatives on the intestine: differential effects on morphology, barrier function, tight junctions proteins and MAPKinases. Toxicol. Sci. 2012, 130:180-190.
35. Prelusky D.B., Trenholm H.L. Nonaccumulation of residues in swine tissue following extended consumption of deoxynivalenol-contaminated diets. J. Food Sci. 1992, 57:801-802.
36. Sergent T., Parys M., Garsou S., Pussemier L., Schneider Y.J., Larondelle Y. Deoxynivalenol transport across human intestinal Caco-2 cells and its effects on cellular metabolism at realistic intestinal concentrations. Toxicol. Lett. 2006, 164:167-176.
37. Sugita-Konishi Y., Pestka J.J. Differential upregulation of TNF-alpha, IL-6, and IL-8 production by deoxynivalenol (vomitoxin) and other 8-ketotrichothecenes in a human macrophage model. J. Toxicol. Environ. Health A 2001, 64:619-636.
38. Tanaka T., Hasegawa A., Yamamoto S., Lee U.S., Sugiura Y., Ueno Y. Worldwide contamination of cereals by the Fusarium mycotoxins nivalenol, deoxynivalenol, and zearalenone. 1. Survey of 19 countries. J. Agric. Food Chem. 1988, 36:979.
39. Tep J., Videmann B., Mazallon M., Balleydier S., Cavret S., Lecoeur S. Transepithelial transport of fusariotoxin nivalenol: mediation of secretion by ABC transporters. Toxicol. Lett. 2007, 170:248-258.
40. Videmann B., Tep J., Cavret S., Lecoeur S. Epithelial transport of deoxynivalenol: involvement of human P-glycoprotein (ABCB1) and multidrug resistance-associated protein 2 (ABCC2). Food Chem. Toxicol. 2007, 45:1938-1947.
41. Wang F., Graham W.V., Wang Y., Witkowski E.D., Schwarz B.T., Turner J.R. Interferon-γ and tumor necrosis factor-α synergize to induce intestinal epithelial barrier dysfunction by up-regulating Myosin Light Chain Kinase expression. Am. J. Pathol. 2005, 166:409-419.
42. Yamashita S., Konishi K., Yamazaki Y., Taki Y., Sakane T., Sezaki H., Furuyama Y. New and better protocols for a short-term Caco-2 cell culture system. J. Pharm. Sci. 2002, 91:669-679.
43. Yoshinari T., Ohnishi T., Kadota T., Sugita-Konishi Y. Development of a purification method for simultaneous determination of deoxynivalenol and its acetylated and glycosylated derivatives in corn grits and corn flour by liquid chromatography-tandem mass spectrometry. J. Food Prot. 2012, 75:1355-1358.
44. Yoshizawa T. Trichothecenes-chemical, biological, and toxicological aspects. Developments in Food Science 1983, 195-209. Kodansya, Tokyo. Y. Ueno (Ed.).
45. Yoshizawa T., Morooka N. Acute toxicities of new trichothecene mycotoxins: deoxynivalenol and its monoacetate. Food Hyg. Safe. Sci. 1974, 15:261-269.
46. Zhou H.R., Yan D., Pestka J.J. Induction of cytokine gene expression in mice after repeated and subchronic oral exposure to vomitoxin (Deoxynivalenol): differential toxin-induced hyporesponsiveness and recovery. Toxicol. Appl. Pharmacol. 1998, 151:347-358.